<scp>LOXL</scp>2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma

Bing Shao, Xiulan Zhao, Tieju Liu, Yanhui Zhang, Ran Sun, Xueyi Dong, Fang Liu, Nan Zhao, Danfang Zhang, Lili Wu, Yong Wang, Meili Wang, Jie Meng, Xian Lin, Baocun SunJournal of Cellular and Molecular Medicine 2018 · DOI

TL;DR

This study reveals that the protein LOXL2 plays a crucial role in promoting aggressive tumor growth and spread in hepatocellular carcinoma (HCC) by enabling a process called vasculogenic mimicry (VM). By collaborating with the transcription factor SNAIL, LOXL2 appears to drive the formation of tumor-derived blood vessels, leading to increased metastasis and poorer patient outcomes.

What Problem Does This Paper Address?

Hepatocellular carcinoma (HCC) is a deadly cancer with high mortality rates, largely due to its tendency to invade and metastasize. While the formation of blood vessels by endothelial cells (angiogenesis) is essential for tumor growth, recent research has shown that aggressive tumor cells can also form their own vascular networks, a process known as vasculogenic mimicry (VM). This VM phenomenon is linked to invasion, metastasis, and poor survival in HCC. However, the molecular mechanisms driving VM in HCC and its specific relationship with proteins like LOXL2 remained unclear. This paper aims to elucidate the role of LOXL2 in promoting VM and tumor aggressiveness in HCC.

Methods

The researchers employed a multi-pronged approach:

  • Immunohistochemistry (IHC): They analyzed tissue samples from 201 HCC patients to assess the expression levels of LOXL2 and its correlation with tumor grade, metastasis, and VM formation.
  • CD31/Periodic Acid-Schiff (PAS) Double Staining: This technique was used to identify and visualize VM structures within the tumor tissues.
  • In Vitro Studies:
    • Cell Culture and Transfection: HCC cell lines were manipulated to either overexpress LOXL2 or silence its expression.
  • Gain and Loss of Function Assays: Migratory, invasion, and tube formation assays were performed on these engineered cell lines to assess the functional impact of LOXL2.
  • 3D Cultures: This method was used to mimic the in vivo environment and observe VM formation by HCC cells.
  • In Vivo Studies:
    • Murine Xenograft Model: HCC cells with altered LOXL2 expression were implanted into immunocompromised mice to evaluate tumor growth, metastasis, and VM formation in a living organism.
  • Western Blot and qRT-PCR: These techniques were used to analyze protein and mRNA expression levels of LOXL2, SNAIL, and other related markers in cell lines and tumor tissues.

Datasets

The study utilized a dataset of 201 human HCC tissue specimens collected between 2001 and 2009. These samples were used for immunohistochemical analysis to correlate LOXL2 expression with clinicopathological variables, VM, and patient survival. Additionally, established HCC cell lines (HepG2, HepG3B, SMMC7721, Bel7402) were used for in vitro experiments.

Key Insights and Ideas

  • LOXL2 is a key driver of VM in HCC: The study provides strong evidence that LOXL2 expression is significantly elevated in HCC and directly promotes the formation of VM networks. This is a critical finding as VM is a mechanism by which tumors can sustain their growth and spread independently of traditional angiogenesis.
  • LOXL2's collaboration with SNAIL is crucial: The research uncovers a critical interaction where LOXL2 appears to upregulate the expression of SNAIL, a known transcription factor involved in epithelial-mesenchymal transition (EMT). This partnership is proposed as the mechanism by which LOXL2 drives VM.
  • VM and LOXL2 are independent predictors of poor prognosis: The findings highlight that both the presence of VM and high LOXL2 expression are independently associated with a worse prognosis for HCC patients, suggesting their utility as diagnostic and prognostic markers.
  • LOXL2 influences multiple aspects of tumor aggressiveness: Beyond VM, LOXL2 was shown to enhance cell migration and invasion, further contributing to the aggressive nature of HCC.

Key Results

  • Clinical Correlation: LOXL2 cytoplasmic expression was significantly correlated with tumor grade, metastasis, and VM formation in 201 HCC patients. Patients with both VM and high LOXL2 cytoplasmic expression had significantly shorter overall and disease-free survival.
  • In Vitro Effects: Overexpression of LOXL2 in HCC cells significantly increased their migration, invasion, and ability to form tube-like structures (VM) in 3D cultures. Conversely, silencing LOXL2 reduced these aggressive behaviors.
  • Mechanism: LOXL2 overexpression led to increased SNAIL expression, which in turn promoted VM. This was supported by findings showing that SNAIL overexpression mimicked LOXL2's effects on VM and that LOXL2 and SNAIL expression were positively correlated.
  • In Vivo Validation: In mouse models, LOXL2 overexpression promoted tumor growth and VM formation, while LOXL2 knockdown reduced tumor growth and metastasis.

Limitations and Future Work

  • Mechanism Complexity: While the study proposes a strong link between LOXL2, SNAIL, and VM, the precise molecular cascade and the interplay with other factors like VE-cadherin and LLGL2 warrant further detailed investigation.
  • Therapeutic Targeting: The authors suggest that LOXL2 could be a potential therapeutic target for inhibiting HCC metastasis. Future research could focus on developing and testing LOXL2-specific inhibitors in preclinical and clinical settings.
  • Broader Implications: The findings on LOXL2 and VM in HCC could potentially be extended to other cancer types where VM is a significant factor in progression.

Summary updated

Abstract

Lysyl oxidase-like 2 (LOXL2) has shown to promote metastasis and poor prognosis in hepatocellular carcinoma (HCC). Also, we have previously reported that vasculogenic mimicry (VM) is associated with invasion, metastasis and poor survival in HCC patients. In the present study, we investigated molecular function of LOXL2 in HCC and VM. We used the immunohistochemical and CD31/periodic acid-Schiff double staining to detect the relationship between LOXL2 and VM formation. We performed the gain and loss of function studies and analysed the migratory, invasion and tube formation in HCC cell lines. We analysed the function of LOXL2 in VM formation and HCC metastasis both in vitro and in vivo. We have showed that LOXL2 was overexpression in HCC and was positively correlated with tumour grade, metastasis, VM formation and poor survival in 201 HCC patients. Secondly, our studies have showed that LOXL2 overexpression in HCC cells significantly promoted migration, invasion and tube formation. Finally, we found that LOXL2 may increase SNAIL expression, thereby enabling VM. Our study indicated that LOXL2 may promote VM formation and tumour metastasis by collaborating with SNAIL in HCC. What's more, the overexpression of LOXL2 indicated a poor prognosis in HCC patients.
BibTeX
@article{shao2018scp,
  author = {Bing Shao and Xiulan Zhao and Tieju Liu and Yanhui Zhang and Ran Sun and Xueyi Dong and Fang Liu and Nan Zhao and Danfang Zhang and Lili Wu and Yong Wang and Meili Wang and Jie Meng and Xian Lin and Baocun Sun},
  title = {{<scp>LOXL</scp>2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma}},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2018},
  doi = {10.1111/jcmm.14039},
}
Figure